PEG-Modified
PEGylation
calix[8]arenes
cytotoxicity
inclusion complexes
silibinin
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
27 Nov 2021
27 Nov 2021
Historique:
received:
19
10
2021
revised:
12
11
2021
accepted:
24
11
2021
entrez:
28
12
2021
pubmed:
29
12
2021
medline:
29
12
2021
Statut:
epublish
Résumé
The hepatoprotective properties of silibinin, as well its therapeutic potential as an anticancer and chemo-preventive agent, have failed to progress towards clinical development and commercialization due to this material's unfavorable pharmacokinetics and physicochemical properties, low aqueous solubility, and chemical instability. The present contribution is focused on the feasibility of using PEGylated calixarene, in particular polyoxyethylene-derivatized
Identifiants
pubmed: 34959307
pii: pharmaceutics13122025
doi: 10.3390/pharmaceutics13122025
pmc: PMC8709077
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Bulgarian Ministry of Education and Science
ID : D01-217/30.11.2018
Références
Anticancer Agents Med Chem. 2020;20(15):1787-1796
pubmed: 31858905
Scand J Gastroenterol. 1982 Jun;17(4):517-21
pubmed: 6753109
Int J Pharm. 2010 Dec 15;402(1-2):10-9
pubmed: 20858540
Chem Commun (Camb). 2006 Jun 21;(23):2425-38
pubmed: 16758007
Int J Pharm. 2000 Dec 15;211(1-2):37-49
pubmed: 11137337
J Photochem Photobiol B. 2021 Mar;216:112147
pubmed: 33561689
Langmuir. 2008 Aug 19;24(16):8522-6
pubmed: 18627190
Nat Prod Rep. 2014 Sep;31(9):1138-57
pubmed: 24977260
Mater Sci Eng C Mater Biol Appl. 2014 Aug 1;41:274-82
pubmed: 24907761
Biomed Pharmacother. 2019 Feb;110:803-817
pubmed: 30554119
J Pharm Biomed Anal. 2016 Jan 5;117:453-63
pubmed: 26454338
J Pharm Sci. 2009 Nov;98(11):4119-29
pubmed: 19226635
Int J Pharm. 2011 Jul 15;413(1-2):245-53
pubmed: 21549187
J Vet Intern Med. 2013 Jan-Feb;27(1):10-6
pubmed: 23140176
Drugs. 2001;61(14):2035-63
pubmed: 11735632
Bioconjug Chem. 2001 Sep-Oct;12(5):655-72
pubmed: 11562183
Carbohydr Res. 2007 Sep 3;342(12-13):1781-92
pubmed: 17517383
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Phytother Res. 2010 Oct;24(10):1423-32
pubmed: 20564545
Drug Dev Ind Pharm. 2010 Oct;36(10):1225-34
pubmed: 20545506
Int J Pharm. 2012 Oct 15;436(1-2):410-7
pubmed: 22766446
Int J Pharm. 2014 Sep 10;472(1-2):165-74
pubmed: 24954662
Artif Cells Nanomed Biotechnol. 2018 May;46(3):524-535
pubmed: 28509572
Molecules. 2017 Nov 10;22(11):
pubmed: 29125572
J Colloid Interface Sci. 2010 Jun 15;346(2):405-13
pubmed: 20338571
Molecules. 2019 Jun 07;24(11):
pubmed: 31181687
Curr Med Chem. 2007;14(3):315-38
pubmed: 17305535
J Phys Chem B. 2008 Feb 21;112(7):1899-905
pubmed: 18220379
Eur J Med Chem. 2016 Feb 15;109:36-46
pubmed: 26748997
Anal Biochem. 1984 Jun;139(2):408-12
pubmed: 6476378
Br J Haematol. 1999 Nov;107(2):365-80
pubmed: 10583226
Chem Commun (Camb). 2011 Sep 21;47(35):9764-72
pubmed: 21629880
Acta Pharmacol Sin. 2007 Feb;28(2):296-306
pubmed: 17241534
Acc Chem Res. 2003 Apr;36(4):246-54
pubmed: 12693922